Journals / Romatoloji ve Tıbbi Rehabilitasyon Dergisi / 1999 / Cilt: 10 - Sayı: 1

Two rheumatoid arthritis cases with pancytopenia due to low dose methotrexate therapy

Düşük doz metotreksat tedavisine bağlı pansitopeni gelişen iki romatoid artrit olgusu

Pages
45–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aim to identify the possible risk factors for pancytopenia due to low-dose methotrexate therapy and compare our two cases with the other cases with pancytopenia reported in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Methotrexate is one of the most effective therapies for rheumatoid arthritis.
📊
Key Findings & Data:Pancytopenia due to low-dose methotrexate therapy is a rare side effect.
💡
Conclusion & Impact:We aim to identify the possible risk factors for pancytopenia due to low-dose methotrexate therapy and compare our two cases with the other cases with pancytopenia reported in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Methotreksat · Pansitopeni · Risk faktörleri

Abstract

Methotrexate is one of the most effective therapies for rheumatoid arthritis. Pancytopenia due to low-dose methotrexate therapy is a rare side effect. In this study, we present two rheumatoid arthritis cases with pancy¬topenia due to methotrexate therapy. We aim to identify the possible risk factors for pancytopenia due to low-dose methotrexate therapy and compare our two cases with the other cases with pancytopenia reported in the literature.

Özet

Metotreksat romatoid artrit tedavisine girmiş en. etkin tedavi yöntemlerinden biridir. Düşük-doz metotreksat tedavisine bağlı pansitopeni gelişmesi nadir görülen bir yan etkidir. Bu çalışmada düşük-doz metotreksat tedavisine bağlı pansitopeni gelişen iki romatoid artrit olgusu sunulmuştur. Bizim iki olgumuz ile birlikte literatürde pansitopeni gelişen diğer olgular karşılaştırılarak, düşük-doz metotreksat tedavisinde pansitopeni gelişmesinde rol oynayabilecek risk faktörleri belirlenmeye çalışılmıştır.

🔖

Cite This Article

KARAKOÇ, Y., YAVUZ, M., YURTKURAN, M., ÖZKALEMKAŞ, F., DİLEK, K., GÜLLÜLÜ, M., ERSOY, A., USTA, M., YURTKURAN, M. (1999). Two rheumatoid arthritis cases with pancytopenia due to low dose methotrexate therapy. Romatoloji ve Tıbbi Rehabilitasyon Dergisi, Cilt: 10 - Sayı: 1, 45–48. https://ajindex.com/articles/302120